TRIAL LOCATIONS

The Phase III clinical trial DIAGNODE-3 is recruiting recently diagnosed type 1 diabetes patients at selected clinics.

TAKING PART IN THE TRIAL

Contact a clinic to register your interest in taking part in the trial. Participation is voluntary and you may discontinue participation at any time. Personal data is processed in accordance with applicable law. Further information about the trial may be obtained by contacting a clinic.

DIAGNODE-3
COORDINATING INVESTIGATOR
Professor Johnny Ludvigsson
  Crown Princess Victoria Children’s Hospital, Sweden
 

A double-blind, placebo-controlled intervention trial, where Diamyd® (rhGAD65) or placebo is administered directly into lymph nodes. The trial evaluates how effectively beta cell function and glycemic control can be preserved in those who carry the HLA DR3 DQ2 haplotype and have recently been diagnosed with type 1 diabetes.


PARTICIPATING CLINICS

California

Newport Beach
Mary & Dick Allen Diabetes Center at Hoag Hospital
  520 Superior St. Newport Beach, CA 92663
  NOT YET RECRUITING

California

San Diego
UCSD/ Rady Children's Hospital
  3020 Children's Way, MC 5105 San Diego, CA 92123
  NOT YET RECRUITING

California

Palo Alto
Stanford University School of Medicine Center for Academic Medicine
  453 Quarry Road, Stanford, CA 94304
  NOT YET RECRUITING

Colorado

Aurora
University of Colorado Anschutz Medical Campus, Barbara Davis Center for Childhood Diabetes
  1775 Aurora Court Aurora, CO 80045
  NOT YET RECRUITING

Florida

Miami
Diabetes Research Institute (DRI)-University of Miami Leonard M. Miller School of Medicine (UMMSM)
  1450 Northwest 10th Avenue Miami, FL 33136
  NOT YET RECRUITING

Idaho

Idaho Falls
Rocky Mountain Diabetes and Osteoporosis Center
  3910 Washington Parkway Idaho Falls, ID 83404
Principal Investigator: Dr Joshua Smith
 
Contact: Joann Malone
 
Contact: Joseph Rogers
 
  208-528-9650
  RECRUITING

Iowa

Iowa City
University of Iowa Hospital and Clinics
  200 Hawkins Dr. BT2015 Iowa City, IA52242
  NOT YET RECRUITING

Maryland

Baltimore
Johns Hopkins
  600 N. Caroline St. #2008, Baltimore, MD 21287
  NOT YET RECRUITING

Massachusetts

Boston
Joslin Diabetes Center
  One Joslin Place Boston, MA 02215
  NOT YET RECRUITING

Missouri

St. Louis
Washington University Diabetes Center at Barnes Jewish Hospital
  4921 Parkview Place St. Louis, MO 63110
  NOT YET RECRUITING

Oregon

Bend
Endocrinology Service Northwest
  929 SW Simpson, Suite B220 Bend, OR 97702
Principal Investigator: Dr. Travis Monchamp
 
Contact: Kathi Pickett
 
  541-706-3801
  RECRUITING

Texas

San Antonio
Diabetes & Glandular Disease Clinic
  5107 Medical drive San Antonio, TX 78237
Principal Investigator: Dr Mark Kipnes
 
  RECRUITING
 

SAFETY

Diamyd® has been administered to more than 1500 patients in clinical trials and has presented a favorable safety profile